MEDICINOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
MEDICINOVA, INC. (MNOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-10
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $1.10M, a 22.22% increase from fiscal 2024.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $900.00K, a 0.00% change from fiscal 2023.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $900.00K, a 65.38% decline from fiscal 2022.
- MEDICINOVA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $2.60M, a 38.10% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-10 |
| 2024-12-31 | $900.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $900.00K 10-K · filed 2025-02-19 |
| 2022-12-31 | $2.60M 10-K · filed 2024-02-15 |
| 2021-12-31 | $4.20M 10-K/A · filed 2023-03-28 |
| 2020-12-31 | $3.70M 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |